Results 111 to 120 of about 177,264 (261)

Daily use of phosphodiesterase type 5 inhibitors as prevention for recurrent priapism.

Revista da Associação Médica Brasileira, 2017
OBJECTIVE The pathogenesis of recurrent priapism is currently being investigated based on the regulation of the phosphodiesterase 5 (PDE5) enzyme. We explored the daily use of PDE5 inhibitors to treat and prevent priapism recurrences.
A. Nardozza, Marcelo R. Cabrini
semanticscholar   +1 more source

The Selective Phosphodiesterase-5 Inhibitor Tadalafil Induces Microvascular and Metabolic Effects in Type 2 Diabetic Postmenopausal Females [PDF]

, 2012
Giuseppe Murdolo, Mikaela Sjöstrand, Lena Strindberg, Peter Lönnroth, Per‐Anders Jansson   +4 more
openalex   +1 more source

Are phosphodiesterase type 5 inhibitors effective for the management of lower urinary symptoms suggestive of benign prostatic hyperplasia?

World Journal of Nephrology, 2015
AIM To review the efficacy of phosphodiesterase type 5 inhibitors (PDE5-Is) in lower urinary tract symptoms (LUTS) suggestive of benign prostate hyperplasia (LUTS/BPH).
Li Tao Zhang, J. K. Park
semanticscholar   +1 more source

Tadalafil in the treatment of erectile dysfunction

Therapeutics and Clinical Risk Management, 2008
Robert M Coward, Culley C CarsonDivision of Urologic Surgery, University of North Carolina, Chapel Hill, NC, USAAbstract: The treatment for erectile dysfunction (ED) was revolutionized with the development of phosphodiesterase type 5 (PDE5) inhibitors ...
Robert M Coward, Culley C Carson
doaj  

Pharmacokinetic, metabolic stability, plasma protein binding and CYP450s inhibition/induction assessment studies of N-(2-pyridylmethyl)-2-hydroxiymethyl-1-pyrrolidinyl-4-(3-chloro-4-methoxy-benzylamino)-5-pyrimidine-carboxamide as potential type 5 phosphodiesterase inhibitors [PDF]

, 2019
Haijun Qu, Xiaoxiao Hu, Xiaoli Shi, Chuan Wang, Longyuan Wang, Guoping Wang   +5 more
openalex   +1 more source

The effects of sildenafil ciltrate on the lateral geniculate body of adult Wistar rats (Rattus norvegicus)- A histological study [PDF]

, 2010
The histological effect of oral administration of sildenafil citrate (Viagra), commonly used as an aphrodisiac and for the treatment of erectile dysfunction on one of the visual relay centres namely the lateral geniculate body (LGB) of adult Wistar rat ...
Eweka, A, Eweka, AO
core   +1 more source

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction

Research and Reports in Urology, 2013
Mauro Gacci,1 Matteo Salvi,1 Arcangelo Sebastianelli,1 Linda Vignozzi,2 Giovanni Corona,3 Kevin T McVary,4 Steven A Kaplan,5 Mario Maggi,2 Marco Carini,1 Matthias Oelke6 1Department of Urology, University of Florence, Florence, 2Sexual Medicine and ...
Gacci M, Salvi M, Sebastianelli A, Vignozzi L, Corona G, McVary KT, Kaplan SA, Maggi M, Carini M, Oelke M   +9 more
doaj  

Peculiarities of correction of sexual function in men presenting with diabetes mellitus

Сахарный диабет, 2010
Diabetes mellitus (DM) is frequently associated with disturbances of the sexual function underlain by hypogonadism and neuropathy. These pathologicalconditions are successfully managed by androgens, alpha-lipoic acid, and phosphodiesterase type 5 ...
Roman Viktorovich Rozhivanov, Alexander Evgen'evich Lepetukhin, Sergey Anatol'evich Dubskiy, Dmitriy Gennad'evich Kurbatov   +3 more
doaj   +1 more source

Predictive value of systemic inflammatory response index in patients with erectile dysfunction on tadalafil unresponsive patients

The Aging Male
Background Erectile dysfunction (ED) is a common disorder that significantly impacts quality of life, and phosphodiesterase type 5 inhibitors (PDE5is) such as tadalafil are one of the primary treatments.
Resul Sobay
doaj   +1 more source

The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

Urology Research and Practice, 2019
Phosphodiesterase type-5 (PDE-5) inhibitors are approved as the first line of therapy for the treatment of erectile dysfunction. However, different studies have been performed to study the use of these agents in other areas of urology.
Mehmet UMUL, Tekin Ahmet SEREL
doaj   +1 more source